Making Access Happen
As we know, timely access to affordable and appropriate medications can significantly improve health outcomes and enhance quality of life. By expanding treatment options and promoting competition, generic and biosimilar medicines can improve access, sustainability of healthcare systems, and alleviate the societal burden of untreated illnesses.
Patient organisations provide a powerful voice for patients and can help policymakers understand the perspectives of the patient community as they work to implement better health policies. Many of our members play a vital role in enhancing access to medicines, educating their communities and empowering patients to make informed decisions.
Recently, ASIF participated alongside 30 patient advocacy leaders from 18 countries, in the Making Access Happen: Sandoz Global Access Forum.
One of the key highlights of the Forum was the Making Access Happen Consensus Statement, co-created with patient advocates worldwide, that addresses key strategies to make healthcare more accessible through generic and biosimilar medicines. The contributors outline 6 key actions:
Together, the patient advocates agreed that collaboration between patient organisations, healthcare providers, policymakers, pharmaceutical companies, and other stakeholders is essential for driving initiatives that improve access to medicines.
Our members can join the conversation on social media using #MakingAccessHappen. We will be sharing social posts about the campaign and encourage our members to share our posts or contact us for access to the content.
Other NEWS
The Pursuit of Remission and Improved Quality of Life in axSpA
Join the Global Alliance for Patient Access (GAfPA) and ASIF’s …
Read More